These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15648301)
1. [Selection and pharmacological characterisation of Procoralan, a selective inhibitor of the pacemaker If current]. Vilaine JP Therapie; 2004; 59(5):495-505. PubMed ID: 15648301 [TBL] [Abstract][Full Text] [Related]
2. [The discovery of the selective If current inhibitor ivabradine (Procoralan): a new therapeutic approach to ischemic heart disease]. Vilaine JP Med Sci (Paris); 2006 Jan; 22(1):87-94. PubMed ID: 16386229 [TBL] [Abstract][Full Text] [Related]
3. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. DiFrancesco D; Camm JA Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560 [TBL] [Abstract][Full Text] [Related]
4. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Vilaine JP Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639 [TBL] [Abstract][Full Text] [Related]
5. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. Perry CM Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944 [TBL] [Abstract][Full Text] [Related]
6. Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257. Thollon C; Bidouard JP; Cambarrat C; Lesage L; Reure H; Delescluse I; Vian J; Peglion JL; Vilaine JP Eur J Pharmacol; 1997 Nov; 339(1):43-51. PubMed ID: 9450615 [TBL] [Abstract][Full Text] [Related]
7. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Thollon C; Bedut S; Villeneuve N; Cogé F; Piffard L; Guillaumin JP; Brunel-Jacquemin C; Chomarat P; Boutin JA; Peglion JL; Vilaine JP Br J Pharmacol; 2007 Jan; 150(1):37-46. PubMed ID: 17128289 [TBL] [Abstract][Full Text] [Related]
8. Novel If current inhibitor ivabradine: safety considerations. Savelieva I; Camm AJ Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474 [TBL] [Abstract][Full Text] [Related]
9. [Ivabradine (Procoralan)]. Lancellotti P Rev Med Liege; 2008 Apr; 63(4):220-4. PubMed ID: 18575078 [TBL] [Abstract][Full Text] [Related]
10. Anti-ischaemic effect of ivabradine. Ferrari R; Cargnoni A; Ceconi C Pharmacol Res; 2006 May; 53(5):435-9. PubMed ID: 16644235 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Thollon C; Cambarrat C; Vian J; Prost JF; Peglion JL; Vilaine JP Br J Pharmacol; 1994 May; 112(1):37-42. PubMed ID: 8032660 [TBL] [Abstract][Full Text] [Related]
12. Heart rate reduction by pharmacological If current inhibition. Cargnoni A; Ceconi C; Stavroula G; Ferrari R Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470 [TBL] [Abstract][Full Text] [Related]
15. Bradycardic and proarrhythmic properties of sinus node inhibitors. Stieber J; Wieland K; Stöckl G; Ludwig A; Hofmann F Mol Pharmacol; 2006 Apr; 69(4):1328-37. PubMed ID: 16387796 [TBL] [Abstract][Full Text] [Related]
16. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina. Sulfi S; Timmis AD Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297 [TBL] [Abstract][Full Text] [Related]